Suppr超能文献

米氏链球菌在接触达托霉素后,其高水平达托霉素耐药性的早期体外和体内发展是常见的。

Early in vitro and in vivo development of high-level daptomycin resistance is common in mitis group Streptococci after exposure to daptomycin.

机构信息

Infectious Diseases Service, University of Barcelona, Barcelona, Spain.

出版信息

Antimicrob Agents Chemother. 2013 May;57(5):2319-25. doi: 10.1128/AAC.01921-12. Epub 2013 Mar 11.

Abstract

The development of high-level daptomycin resistance (HLDR; MIC of ≥ 256 mg/liter) after exposure to daptomycin has recently been reported in viridans group streptococcus (VGS) isolates. Our study objectives were as follows: to know whether in vitro development of HLDR after exposure to daptomycin was common among clinical isolates of VGS and Streptococcus bovis; to determine whether HLDR also developed during the administration of daptomycin to treat experimental endocarditis caused by the daptomycin-susceptible, penicillin-resistant Streptococcus mitis strain S. mitis 351; and to establish whether combination with gentamicin prevented the development of HLDR in vitro and in vivo. In vitro studies were performed with 114 VGS strains (mitis group, 92; anginosus group, 10; mutans group, 8; and salivarius group, 4) and 54 Streptococcus bovis strains isolated from 168 consecutive patients with infective endocarditis diagnosed between 1995 and 2010. HLDR was only observed after 24 h of exposure to daptomycin in 27% of the mitis group, including 27% of S. mitis isolates, 47% of S. oralis isolates, and 13% of S. sanguis isolates. In our experimental model, HLDR was detected in 7/11 (63%) and 8/12 (67%) isolates recovered from vegetations after 48 h of daptomycin administered at 6 mg/kg of body weight/24 h and 10 mg/kg/24 h, respectively. In vitro, time-kill experiments showed that daptomycin plus gentamicin was bactericidal against S. mitis 351 at tested concentrations of 0.5 and 1 times the MIC and prevented the development of HLDR. In vivo, the addition of gentamicin at 1 mg/kg/8 h to both daptomycin arms prevented HLDR in 21 out of 23 (91%) rabbits. Daptomycin plus gentamicin was at least as effective as vancomycin plus gentamicin. In conclusion, HLDR develops rapidly and frequently in vitro and in vivo among mitis group streptococci. Combining daptomycin with gentamicin enhanced its activity and prevented the development of HLDR in most cases.

摘要

高浓度达托霉素耐药性(HLDR;MIC≥256mg/L)在达托霉素暴露后最近在草绿色链球菌(VGS)分离株中被报道。我们的研究目的如下:了解 VGS 和牛链球菌临床分离株中达托霉素暴露后 HLDR 的体外发展是否常见;确定 HLDR 是否也在达托霉素治疗达托霉素敏感、青霉素耐药性米氏链球菌 S. mitis 351 引起的实验性心内膜炎时发展;并确定与庆大霉素联合是否可以防止体外和体内 HLDR 的发展。体外研究使用了 114 株 VGS 株(米氏组 92 株;咽峡炎组 10 株;变异链球菌组 8 株;和唾液链球菌组 4 株)和 1995 年至 2010 年间连续诊断为感染性心内膜炎的 168 例患者分离的 54 株牛链球菌。在米氏组中,27%的菌株(包括 27%的米氏链球菌分离株、47%的 S. oralis 分离株和 13%的 S. sanguis 分离株)在暴露于达托霉素 24 小时后仅观察到 HLDR。在我们的实验模型中,在以 6mg/kg 体重/24 小时和 10mg/kg/24 小时的剂量给予达托霉素 48 小时后,从植被中回收的 11 个(63%)和 12 个(67%)分离物中检测到 HLDR。体外,时间杀伤实验表明,达托霉素加庆大霉素对测试浓度为 MIC 的 0.5 倍和 1 倍的米氏链球菌 351 具有杀菌作用,并防止 HLDR 的发展。在体内,在达托霉素臂中以 1mg/kg/8h 的剂量添加庆大霉素可防止 23 只(91%)兔子中的 21 只(91%)发生 HLDR。达托霉素加庆大霉素的疗效至少与万古霉素加庆大霉素一样好。总之,HLDR 在米氏链球菌中快速且频繁地在体外和体内发展。达托霉素与庆大霉素联合使用可增强其活性,并在大多数情况下防止 HLDR 的发展。

相似文献

引用本文的文献

7

本文引用的文献

6
Genetic basis for daptomycin resistance in enterococci.肠球菌中达托霉素耐药的遗传基础。
Antimicrob Agents Chemother. 2011 Jul;55(7):3345-56. doi: 10.1128/AAC.00207-11. Epub 2011 Apr 18.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验